Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T20:45:31.029Z Has data issue: false hasContentIssue false

Antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae urine isolates from a national sample of home-based primary care patients with dementia

Published online by Cambridge University Press:  22 May 2023

Rupak Datta*
Affiliation:
Veterans Affairs Connecticut Healthcare System, West Haven, ConnecticutDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
Gabrielle Pirruccio
Affiliation:
Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut
Terri R. Fried
Affiliation:
Veterans Affairs Connecticut Healthcare System, West Haven, ConnecticutDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
John R. O’Leary
Affiliation:
Veterans Affairs Connecticut Healthcare System, West Haven, ConnecticutDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
Andrew R. Zullo
Affiliation:
Department of Epidemiology, Brown University School of Public Health, Providence, Rhode IslandCenter of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, Rhode Island
Andrew Cohen
Affiliation:
Veterans Affairs Connecticut Healthcare System, West Haven, ConnecticutDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
*
Corresponding author: Rupak Datta, E-mail: rupak.datta@yale.edu
Rights & Permissions [Opens in a new window]

Abstract

Annual prevalences of antimicrobial resistance among urine isolates (3,913 Escherichia coli isolates and 1,736 Klebsiella pneumoniae isolates) from home-based primary care patients with dementia were high between 2014 and 2018 (ciprofloxacin, 18%–23% and 5%–7%, respectively; multidrug resistance, 9%–11% and 5%–6%, respectively). Multidrug resistance varied by region. Additional studies of antimicrobial resistance in home-care settings are needed.

Information

Type
Concise Communication
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Fig. 1.Annual prevalence of antimicrobial nonsusceptibility when evaluating (A) the first E. coli urine isolate and (B) the first K. pneumoniae urine isolate collected per patient per year from homebound older adults with dementia who received home-based primary care through the Veterans Affairs Healthcare System in 2014–2018. The numbers of the first E. coli urine isolates and the first K. pneumoniae urine isolates collected per year are as follows: 2014 (n = 573 and n = 259), 2015 (n = 724 and n = 302), 2016 (n = 822 and n = 383), 2017 (n = 862 and n = 383), 2018 (n = 932 and n = 409). Note. CIP, ciprofloxacin; AMS, ampicillin-sulbactam, TRS, trimethoprim-sulfamethoxazole; 3GC, third-generation cephalosporins; GEN, gentamicin; PIT, piperacillin-tazobactam; MER, meropenem; MDR, multidrug.

Figure 1

Table 1.Patient-Level Characteristics of Homebound Older Adults With Dementia From Whom a Urine Escherichia coli or Klebsiella pneumoniae Isolate Was Collected After Enrollment in Home-Based Primary Care, 2014–2018

Supplementary material: File

Datta et al. supplementary material

Datta et al. supplementary material

Download Datta et al. supplementary material(File)
File 15.4 KB